NCT03341039View on ClinicalTrials.gov

PHIL Evaluation in the Endovascular Treatment of Intracranial Cerebral ArterioVenous Malformation (cAVM)

TerminatedOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

November 14, 2017

Primary Completion Date

October 14, 2020

Study Completion Date

October 14, 2020

Conditions
Cerebral AV Malformation
Trial Locations (16)

2100

Rigshospitalet University, Copenhagen

28006

Hospital Nuestra Senora del Rosario, Madrid

29010

Hospital Regional Universitario Carlos Haya, Málaga

30120

Hospital Universitario Virgen de la Arrixaca, Murcia

31059

Hôpital Pierre Paul Riquet, Toulouse

33000

CHU Pellgrin, Bordeaux

41013

Hospital Universitario Virgen del Rocio, Seville

75010

La Fondation Rothschild, Paris

75185

Uppsala University, Uppsala

87000

CHU Limoges, Limoges

90746

Universitetssjukhus Umea, Umeå

94270

Hôpital Bicêtre, Le Kremlin-Bicêtre

08190

Hospital Universitario General de Catalunya, Barcelona

B15 2TH

University Hospital Birmingham, Birmingham

EH4 2XU

Western General Hospital, Edinburgh

W 8RF

Charing Cross Hospital, London

Sponsors

Collaborators (1)

ClinSearch
All Listed Sponsors
collaborator

ClinSearch

OTHER

lead

Microvention-Terumo, Inc.

INDUSTRY

NCT03341039 - PHIL Evaluation in the Endovascular Treatment of Intracranial Cerebral ArterioVenous Malformation (cAVM) | Biotech Hunter | Biotech Hunter